Showing results (181-190 of 206) with videos related to
Sort By:
Pageof 21
Vaccine|December 28, 2010
Attitudinal and demographic predictors of measles, mumps and rubella (MMR) vaccine acceptance: development and validation of an evidence-based measurement instrumentKatrina F Brown, Ruth Shanley, Noel A L Cowley, et al.Age and Ageing|July 25, 2021
An intervention to increase physical activity in care home residents: results of a cluster-randomised, controlled feasibility trial (the REACH trial)Anne Forster, Jennifer Airlie, Alison Ellwood, et al.Lancet (London, England)|October 22, 2013
Clinical and cost-effectiveness of cognitive behaviour therapy for health anxiety in medical patients: a multicentre randomised controlled trialPeter Tyrer, Sylvia Cooper, Paul Salkovskis, et al.Plos One|January 29, 2025
The impact of specialised gastroenterology services for pelvic radiation disease (PRD): Results from the prospective multi-centre EAGLE studyJohn N Staffurth, Stephanie Sivell, Elin Baddeley, et al.Trials|August 9, 2015
Prevention of delirium (POD) for older people in hospital: study protocol for a randomised controlled feasibility trialJohn Young, Francine Cheater, Michelle Collinson, et al.Journal of Pediatric Gastroenterology and Nutrition|April 10, 2019
Paediatric Endoscopy Global Rating Scale: Development of a Quality Improvement Tool and Results of a National PilotPriya Narula, Raphael Broughton, Lucy Howarth, et al.Health Technology Assessment (Winchester, England)|September 10, 2024
Community-based complex interventions to sustain independence in older people, stratified by frailty: a systematic review and network meta-analysisThomas Frederick Crocker, Natalie Lam, Joie Ensor, et al.Gynecologic Oncology|May 28, 2019
Phase 2 study of anastrozole in recurrent estrogen (ER)/progesterone (PR) positive endometrial cancer: The PARAGON trial - ANZGOG 0903Linda Mileshkin, Richard Edmondson, Rachel L O'Connell, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 25, 2013
Randomized phase III study of erlotinib versus observation in patients with no evidence of disease progression after first-line platin-based chemotherapy for ovarian carcinoma: a European Organisation for Research and Treatment of Cancer-Gynaecological Cancer Group, and Gynecologic Cancer Intergroup studyIgnace B Vergote, Antonio Jimeno, Florence Joly, et al.BMJ (Clinical Research Ed.)|March 21, 2024
Community based complex interventions to sustain independence in older people: systematic review and network meta-analysisThomas F Crocker, Joie Ensor, Natalie Lam, et al.Pageof 21